Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Clinical trial NCT00377429 · COMPLETED
Trial details
- NCT number
- NCT00377429
- Sponsor
- Neovii Biotech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2008-02-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.